Drug Profile
Voriconazole nanopolymeric
Alternative Names: SYP-1018; Voriconazole-loaded PNP; Voriconazole-PNPLatest Information Update: 09 Oct 2021
Price :
$50
*
At a glance
- Originator Samyang Biopharmaceuticals Corporation; Samyang Group
- Developer Samyang Biopharmaceuticals Corporation
- Class Antifungals; Fluorinated hydrocarbons; Pyrimidines; Small molecules; Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Mycoses
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Mycoses in South Korea (IV)
- 31 May 2015 Final adverse events and pharmacokinetic data from a phase I trial in healthy volunteers released by Samyang Biopharmaceuticals
- 30 Nov 2012 Samyang completes a phase I trial in Healthy volunteers in South Korea (NCT01657201)